Cell kinetics and practical consequences for therapy of acute leukemia.
D000305:Adrenal Cortex Hormones / Q000494:pharmacology / Q000627:therapeutic use; D001215:Asparaginase / Q000494:pharmacology / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D001854:Bone Marrow Cells; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003561:Cytarabine / Q000494:pharmacology / Q000627:therapeutic use; D004247:DNA / Q000096:biosynthesis; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003630:Daunorubicin / Q000494:pharmacology / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy* / Q000473:pathology; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008727:Methotrexate / Q000494:pharmacology / Q000627:therapeutic use; D008938:Mitosis; D011379:Prognosis; D014750:Vincristine / Q000494:pharmacology / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D004273:DNA, Neoplasm; D003561:Cytarabine; D014750:Vincristine; D004247:DNA; D001215:Asparaginase; D008727:Methotrexate; D003630:Daunorubicin